About Bradford Sippy
Form D filings for Lennham Pharmaceuticals from 2021 to 2023 list Bradford Sippy as CEO and director.
Bradford Sippy first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Bradford Sippy in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bradford Sippy works with at each company, as listed on that company's latest Form D.
Lennham Pharmaceuticals, Inc. · Form D, Apr 4, 2023
BE
Benjamin Enerson
Executive officer
CM
Corey MacGregor
Executive officer